Multiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another
Rob Sahr
Advertisement
Articles by Rob Sahr
Advertisement
Latest Updated Articles
Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patentingPublished: January 28th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio
2
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients
3
Direct-to-Patient (DTP): Who Benefits - and Why It’s Different
4
Why AI-Augmented Traceability Hubs are the Future of Pharma Serialization
5
